Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus

2013449 citationsJournal Article

Authors

Sonal Singh · Johns Hopkins Medicine

Hsien‐Yen Chang · Johns Hopkins University

Thomas M. Richards · Johns Hopkins University

Jonathan P. Weiner · Johns Hopkins University

Jeanne M. Clark · Johns Hopkins Medicine

Jodi B Segal · Johns Hopkins Medicine

Abstract

In this administrative database study of US adults with type 2 diabetes mellitus, treatment with the GLP-1-based therapies sitagliptin and exenatide was associated with increased odds of hospitalization for acute pancreatitis.

Topics & Keywords

Pancreatitis Pathology and Treatment Diabetes Treatment and Management Pancreatic and Hepatic Oncology Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Internal Medicine

Volume 173, Issue 7, pp. 534-534

DOI: 10.1001/jamainternmed.2013.2720

Field-Weighted Citation Impact: 73.50